KOREAN
Company Business R & D Investors

Global Stem Cell Company

Investors

Notice IR
Disclosure Information Stock Information IR Resource Center IR Letter & FAQ
PR
Press Release PR Resource Center

IR Letter & FAQ

InvestorsIRIR Letter & FAQ

ir@kangstem.com, 02-888-1590

목록으로

[MTN] [점프업바이오] 강스템바이오텍 "인체세포관리업 허가 다음달 초 승인 기대" (21.06.28)

2021.06.28
[MTN] [점프업바이오] 강스템바이오텍 "인체세포관리업 허가 다음달 초 승인 기대"

https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021062810505119343






목록으로

  강스템바이오텍, 첫 번째 임상개시모임의 성공적 수행 (21.07.01)   [비즈니스포스트] 강스템바이오텍 대표 나종천 "아토피치료제 임상 꼭 성공" (21.06.15)
About Us Stock Information Careers Contact Us
Global R&D Center Stem Cell GMP Center Pipeline
TOP
Kangstem Biotech Co., Ltd.
9th Floor, Hongwoo Bldg., 522 Teheran-ro, Gangnam-gu, Seoul

COPYRIGHT © 2015 KANGSTEM BIOTECH ALL RIGHTS RESERVED.
Go
board : irletter : view : : /board/irletter/view